Skip to main content

Table 7 Independent predictors of 30-day death in the statin previous users subset of patients with clinically suspected VAP

From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

  Adjusted hazard ratio 95% CI P
Age 1.06 1.02-1.11 <0.01
SOFA day-1 1.16 1.03-1.32 0.02
Statin continuation after ICU admission 0.47 0.22-0.97 0.04
  1. VAP, ventilator-associated pneumonia; CI, confidence interval; SOFA, sequential organ failure assessment; ICU, intensive care unit.